ONCY · Forms 3, 4, 5
Insider trades at ONCOLYTICS BIOTECH INC
No open-market insider buys or sells at ONCOLYTICS BIOTECH INC in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for ONCOLYTICS BIOTECH INC (ONCY) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for ONCOLYTICS BIOTECH INC in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| John Bearden McAdory | Chief Operating Officer | Became an insider (Form 3) | Form 3 | ||||
| Wayne Pisano | Director | Options or other derivatives | Form 4 | ||||
| Jonathan Rigby | Director | Options or other derivatives | Form 4 | ||||
| Angela Holtham | Director | Options or other derivatives | Form 4 | ||||
| James T. Parsons | Director | Options or other derivatives | Form 4 | ||||
| Kirk Look | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Andrew Aromando | Chief Business Officer | Options or other derivatives | Form 4 | ||||
| Stephen C. Glover | Director | Became an insider (Form 3) | Form 3 | ||||
| Jared Kelly | Chief Executive Officer | Options or other derivatives | Form 4 | ||||
| Patricia S Andrews | Director | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.